GN/AST generic GN AST 20 cards/box
Ended Purchase Order Awarded Last action
- Contract number
- W81K0021P0235
- Awardee
-
Biomerieux Inc. UEI HCNVCMEG9NL6
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $619,454
Award facts
- Opportunity
-
- Microbial, Identification, and Susceptibility Testing, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas Pre-Solicitation · W81K0021Q0001 · Posted May 18, 2021
- Contract value 84% obligated
- $737,210.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27701, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$232,399 | |
| Funding Only Action | -$406,633 | |
| Funding Only Action | -$201,498 | |
| Funding Only Action | $364,671 | |
| Funding Only Action | -$55,256 | |
| Exercise an Option | $0 | |
| Exercise an Option | $364,671 | |
| Funding Only Action | -$201,808 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $415,503 | |
| Exercise an Option | $0 | |
| Funding Only Action | $415,503 | |
| Other Administrative Action | $415,503 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $0 | |
| Original award | $0 |
Show all 19
About this award
The Defense Health Agency awarded a firm-fixed-price purchase order to Biomerieux Inc., doing business as Vitek Systems, Inc., on October 1, 2021, with a ceiling value of $737,210.80 for GN/AST generic GN AST 20 cards per box. The order carries no set-aside designation and is performed in Durham, North Carolina 27701. The current record is a modification that de-obligates excess FY26 funds to reflect actual amounts used during performance from October 1, 2025 through September 30, 2026, with an ultimate completion date of September 30, 2026. The order originated from pre-solicitation notice W81K00-21-Q-0001, posted May 18, 2021 by the Regional Health Contracting Office-Central for the Department of the Army Medical Command. That notice sought cost-per-test automated microbial identification and susceptibility testing at Brooke Army Medical Center, with a base period of October 1, 2021 through September 30, 2022 and four 12-month option periods.
Quick answers
Who was awarded contract W81K0021P0235?
W81K0021P0235 was awarded to Biomerieux Inc. by Medical Command (Department of the Army) on October 1, 2021.
How much is contract W81K0021P0235 worth?
The government has obligated $619,454 on W81K0021P0235. Its current value, with exercised options, is $737,211.
Which agency awarded contract W81K0021P0235?
Medical Command (Department of the Army) awarded W81K0021P0235, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0021P0235 competed?
The extent of competition for W81K0021P0235 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award